ACE and diabetes mellitus: Previous studies indicate that both ACE inhibitors and ARBs may reduce the progression to type 2 diabetes in hypertensive patients; our study provides direct comparative evidence on their relative efficacy in improving IR - a key risk factor for diabetes [19].